Circadian High Intensity Interval Training Study
Type 2 Diabetes, Insulin Independent
About this trial
This is an interventional prevention trial for Type 2 Diabetes focused on measuring Type 2 Diabetes, Insulin independent, HIIT, CGM-based blood glucose
Eligibility Criteria
Inclusion criteria
- Age: 45 - 68 years
- Body Mass Index (BMI): 23 - 33 kg/m2
- Participant diagnosed with Type 2 Diabetes (insulin independent)
- Ability to provide informed consent
- Ability to complete the exercise regiment
Exclusion criteria:
- Medications: Insulin
- Current nicotine user (cigarettes, snus, nicotine gum)
- Past nicotine use less than 6 months before inclusion in the study
- Pre-existing cardiovascular condition: Angina pectoris, Cardiac arrhythmia, Cardiac infarction, Coronary stent / angiography, Cerebrovascular insult, Hypertension
- Pre-existing blood-borne disease: HIV, Hepatitis C, MRSA
- Pre-existing systemic or localized rheumatic illness
- Cancer
- Pre-existing psychiatric disorder
- Another pre-existing systemic disease
Sites / Locations
- Karolinska Institutet
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Morning first
Afternoon first
Both arms of the study will perform the baseline measurements during visit 1. Arm 1 of the study will perform HIIT at 08:30 during visit 2, and after a 1-week washout period will perform HIIT at 19:30 during visit 3. HIIT bout will consist of 3 minutes of warm-up followed by 6 1-minute intervals of full exertion cycling on a cycle ergometer, interspersed by a 1-minute recovery periods and ending with a 3-minute cooldown.
Both arms of the study will perform the baseline measurements during visit 1. Arm 2 of the study will perform HIIT at 19:30 during visit 2, and after a 1-week washout period will perform HIIT at 08:30 during visit 3. HIIT bout will consist of 3 minutes of warm-up followed by 6 1-minute intervals of full exertion cycling on a cycle ergometer, interspersed by a 1-minute recovery periods and ending with a 3-minute cooldown.